World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
19038
World Ranking
18526
National Ranking
261

Xavier Calvet publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Xavier Calvet sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 528 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Xavier Calvet D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Xavier Calvet sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Xavier Calvet is affiliated with the Autonomous University of Barcelona in Spain and has established a significant research presence primarily in the medical sciences, with a prolific output in the fields of medicine and biochemistry, genetics, and molecular biology. Their work spans several specialized subfields, including genetics, surgery, epidemiology, immunology, and gastroenterology.

The scientific interests of Xavier Calvet concentrate chiefly on topics related to inflammatory intestinal conditions and gastrointestinal diseases. Key research themes include inflammatory bowel disease, microscopic colitis, Helicobacter pylori-related gastroenterology studies, gastric cancer management and outcomes, eosinophilic esophagitis, diverticular disease and its complications, as well as biosimilars and bioanalytical methods.

Xavier Calvet's recent academic contributions feature publications in prominent journals, demonstrating focus on therapies and clinical management strategies for inflammatory bowel diseases. Noteworthy recent papers include:

  • Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial (2022, The Lancet)
  • Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study (2021, The Lancet Gastroenterology & Hepatology)
  • Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (2021, Journal of Clinical Medicine)
  • Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry (2021, Journal of Crohn's and Colitis)
  • Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry (2020, Alimentary Pharmacology & Therapeutics)

Collaborations have been a significant aspect of Xavier Calvet's research output. Frequent co-authors include Javier P. Gisbert, Eugeni Domènech, Ana Gutiérrez, Montserrat Rivero, and Manuel Barreiro-de Acosta, reflecting an extensive network within the gastroenterology and inflammatory bowel disease research community.

Xavier Calvet has disseminated research results in several key publication venues, notably:

  • Journal of Crohn's and Colitis
  • Gastroenterología y Hepatología
  • Journal of Clinical Medicine
  • Gastroenterología y Hepatología (English Edition)
  • Endoscopy

The scope of their work reflects an interdisciplinary approach, incorporating clinical, genetic, and molecular biological perspectives to advance understanding and treatment of gastrointestinal disorders. This multidisciplinary focus is evident in the diversity of main fields and subfields associated with Calvet's publications.

Best Publications

  • PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS

    Jordi Bruix;Xavier Calvet;Josep Costa;Miquel Ventura

  • Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.

    Angel Lanas;Luis A García-Rodríguez;Mónica Polo-Tomás;Marta Ponce

  • Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group.

    Alan N. Barkun;Majid Almadi;Ernst J. Kuipers;Loren Laine

  • Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers.

    Xavier Calvet;Mercedes Vergara;Enric Brullet;Javier P. Gisbert

  • Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

    M. Vergara;M. Catalán;J. P. Gisbert;X. Calvet

  • A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

    X Calvet;N García;T López;J P Gisbert

  • Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection

    A. G. McNicholl;P. M. Linares;O. P. Nyssen;X. Calvet

  • Optimum duration of regimens for Helicobacter pylori eradication

    Yuhong Yuan;Alex C Ford;Khurram J Khan;Javier P Gisbert

  • Sequential therapy for Helicobacter pylori eradication: a critical review.

    Javier P Gisbert;Xavier Calvet;Anthony O'Connor;Francis Mégraud

  • Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients.

    Xavier Calvet;Jordi Bruix;Pere Ginés;Concepció Bru

  • Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers.

    Mercedes Vergara;Cathy Bennett;Xavier Calvet;Javier P Gisbert

  • Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication

    Villoria A;Garcia P;Calvet X;Gisbert Jp

  • Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

    M J Casanova;M Chaparro;E Domènech;M Barreiro-de Acosta

  • Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.

    J. P. Gisbert;L. González;X. Calvet;N. García

  • Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants

    Ángel Lanas;Patricia Carrera-Lasfuentes;Yolanda Arguedas;Santiago García

  • Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

    J. P. Gisbert;X. Calvet

  • Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori

    J. P. Gisbert;X. Calvet

  • Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.

    J. P. Gisbert;L. González;X. Calvet;M. Roqué

  • Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

    C. Loras;J. P. Gisbert;M. Mínguez;O. Merino

  • The changing face of hospitalisation due to gastrointestinal bleeding and perforation.

    A. Lanas;A. Lanas;L. A. García-Rodríguez;M. Polo-Tomás;M. Ponce

Frequent Co-Authors

Javier P. Gisbert
Javier P. Gisbert Autonomous University of Madrid
Luis Bujanda
Luis Bujanda University of the Basque Country
Ana Gutiérrez
Ana Gutiérrez Spanish National Research Council
Angel Lanas
Angel Lanas University of Zaragoza
Jordi Bruix
Jordi Bruix University of Barcelona
Juan Rodés
Juan Rodés University of Barcelona
Julián Panés
Julián Panés University of Barcelona
Francis Mégraud
Francis Mégraud University of Bordeaux
David L. Suarez
David L. Suarez United States Department of Agriculture

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a physician. Many students explore related healthcare fields and alternative routes through online degree programs. If flexibility, affordability, or entry requirements are important factors for you, there are several pathways to consider.

For registered nurses looking to advance their qualifications, the cheapest BSN programs offer accredited options that allow you to earn your Bachelor of Science in Nursing without a major financial burden. These programs can help working nurses gain advanced skills and expand their career opportunities.

If you have a non-nursing bachelor’s degree, there are online direct entry MSN programs for non-nursing majors. These accelerated programs help career-changers fast-track into the nursing profession with a Master’s degree.

For those looking for more accessible entry points into healthcare, check out the easiest nursing schools to get into. These institutions focus on making nursing education attainable for a wider range of applicants.

Not all healthcare careers require direct patient care. Those interested in administrative roles can consider the best medical billing and coding schools online. These programs offer flexibility and financial aid, preparing you for in-demand positions in medical offices and hospitals.

Best Scientists Citing Xavier Calvet

Trending Scientists

Recently Published Articles